Agios Pharma (AGIO) Announces Data from AG-519 Phase 1 SAD, MAD; Dose-Dependent Increase in PKR Activity Noted
Tweet Send to a Friend
Agios Pharmaceuticals, Inc. (Nasdaq: AGIO) announced the initial data from the Phase 1 integrated single ascending dose (SAD) and multiple ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
